HealthTech Integrates 2023 Track 1
HealthTech is an integral part of today’s healthcare, how do we ensure delivery of the benefits it offers?
Welcome and opening remarks
Lighting the way
With the advent of RWD, omics data, imaging data, Dx data etc, enabling prediction of disease progression following early diagnosis – can we begin to practice preventative medicine now rather than symptom treatment as we have been?
Louise Jopling | Commercial Director | Eastern Academic Health Science Network
Debora Lucarelli | Chief Executive Officer | Enhanc3D Genomics
Anthony Finbow | Chief Executive Officer | Eagle Genomics
Jane Theaker | Chief Executive Officer | PBD Biotech
Ellie Halliday | Data Privacy & Compliance Manager | Talking Medicines
How does this industry embrace sustainability? Are we going to be able to move away from single-use plastics and enable recycling? Have we got the answer to the carbon costs of data processing and storage etc?
Martin Baxter | Chief Executive Officer | IEMA
Addie MacGregor | Sustainability Executive | ABHI
Michelle Sullivan | Head Of Public Affairs | Boston Scientific
Daniel Coole | Managing Director | Surgical Holdings
Brennan Miles | Head of Drug Delivery | Team Consulting
Pete Waddingham | National NetZero Lead | The AHSN Network
Wear’s my data?
What actionable value can be achieved from wearables data? With multiple owners of these data in multiple formats – how can we join the dots on an individual patient level and enable better informed clinical decision making?
Beverley Vaughan | Innovation Hubs Director | ARISE
Emilė Radytė | Co-founder & CEO | Samphire Neuroscience
Camille Carroll | Honorary Consultant Neurologist | Plymouth Hospitals NHS Trust
Nigel Brokenshire | Head of Digital Healthcare UK/I | Bayer PLC
Rahul Kapoor | Director of Health Tech | CPI
Luca Lipani | Co-Founder & Chief Executive Officer | Transdermal Diagnostics
Navigating the regulatory pathway
How do you prepare your regulatory strategy to enable a rapid route to market? US, EU, UK – selecting the right regulatory pathway?
Hugh Harvey | Managing Director | Hardian Health
Vishal Thakker | Head of UK Approved Body & Senior Regulatory Lead | British Standards Institution (BSI)
Ema Kufel | Co-founder & UK Chief Executive Officer | Prosoma
Mina Frost | Founder & Director | Decode X
James Fry | Partner and Head of Life Sciences | Mills & Reeve
Ama Frimpong | Head of Product Development | 52 North Health
The brightest and the best
The need for Covid-19 testing saw an explosion in the molecular diagnostics arena and rapid adoption – How do we build on that success? (PCR and beyond – facilitating early infectious disease detection)
Pari Datta | Principle Consultant – Strategy/Diagnostics & Life Sciences | Cambridge Design Partnership
John Tyson | Head of the North East Innovation Lab | Newcastle Upon Tyne Hospitals NHS Foundation Trust
Frederick Manduca | Director | Newfoundland Diagnostics
Jonathan O’Halloran | Chief Executive Officer | QuantuMDx Group
Peter Whawell | Chief Executive Officer | Proxximos
Robert Porter | Chief Executive Officer | RAPIvD